1998•Journal watchRequires access

Finasteride for Androgenetic Alopecia

NH Shear

Abstract

In androgenetic alopecia, dihydrotestosterone (DHT) causes miniaturization of scalp hair. Finasteride, an inhibitor of type II 5α- reductase, reduces the conversion of testosterone to DHT in hair follicles and the prostate. The manufacturer and investigators report the results of two one-year, double-blind, randomized, controlled trials of finasteride use in men with androgenetic alopecia conducted in …

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Finasteride, Dihydrotestosterone, Hair loss, Medicine, Testosterone (patch), Scalp, 5 Alpha-Reductase Inhibitor, Dermatology